Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay

C. Gotti, B. Balestra, R. Mantegazza, S. Tzartos, M. Moretti, F. Clementi

Research output: Contribution to journalArticle

Abstract

To investigate the presence of antibodies in myasthenia gravis (MG) patients, we have developed a new reproducible and sensitive enzyme immunoassay (EIA-AChR), in which a β subunit-specific monoclonal antibody (mAb 73) immobilizes fetal calf acetylcholine receptors (AChRs). We tested 92 MG patients (42 with positive and 50 with negative antibody liters), 60 healthy controls, and 40 controls with other autoimmune diseases. EIA-AChR detected immunoglobulin G (IgG) titers in all of the seropositive samples, with a significant correlation between these and those obtained using the traditional immunoprecipitation method. Moreover, 5 seronegative patients at immunoprecipitation assay were positive at EIA-AChR. EIA-AChR was also useful in revealing: (1) a seropositive patient subpopulation with generalized MG who had Abs directed against α-Bungarotoxin binding sites; and (2) patients with IgM directed against fetal calf AChR (detected in 13 seronegative and 16 seropositive MG patients, and in 6 of the patients with other autoimmune diseases).

Original languageEnglish
Pages (from-to)800-808
Number of pages9
JournalMuscle and Nerve
Volume20
Issue number7
DOIs
Publication statusPublished - 1997

Fingerprint

Immunoglobulin Isotypes
Myasthenia Gravis
Immunoenzyme Techniques
Cholinergic Receptors
Immunoprecipitation
Autoimmune Diseases
Bungarotoxins
Antibodies
Immunoglobulin M
Immunoglobulin G
Binding Sites
Monoclonal Antibodies

Keywords

  • Antibodies
  • Enzyme-linked immunosorbent assay
  • Immunoassay
  • Myasthenia gravis
  • Nicotinic acetylcholine receptor

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay. / Gotti, C.; Balestra, B.; Mantegazza, R.; Tzartos, S.; Moretti, M.; Clementi, F.

In: Muscle and Nerve, Vol. 20, No. 7, 1997, p. 800-808.

Research output: Contribution to journalArticle

Gotti, C. ; Balestra, B. ; Mantegazza, R. ; Tzartos, S. ; Moretti, M. ; Clementi, F. / Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay. In: Muscle and Nerve. 1997 ; Vol. 20, No. 7. pp. 800-808.
@article{aa330b9080b04cc8ad1e6e40ae9cfd87,
title = "Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay",
abstract = "To investigate the presence of antibodies in myasthenia gravis (MG) patients, we have developed a new reproducible and sensitive enzyme immunoassay (EIA-AChR), in which a β subunit-specific monoclonal antibody (mAb 73) immobilizes fetal calf acetylcholine receptors (AChRs). We tested 92 MG patients (42 with positive and 50 with negative antibody liters), 60 healthy controls, and 40 controls with other autoimmune diseases. EIA-AChR detected immunoglobulin G (IgG) titers in all of the seropositive samples, with a significant correlation between these and those obtained using the traditional immunoprecipitation method. Moreover, 5 seronegative patients at immunoprecipitation assay were positive at EIA-AChR. EIA-AChR was also useful in revealing: (1) a seropositive patient subpopulation with generalized MG who had Abs directed against α-Bungarotoxin binding sites; and (2) patients with IgM directed against fetal calf AChR (detected in 13 seronegative and 16 seropositive MG patients, and in 6 of the patients with other autoimmune diseases).",
keywords = "Antibodies, Enzyme-linked immunosorbent assay, Immunoassay, Myasthenia gravis, Nicotinic acetylcholine receptor",
author = "C. Gotti and B. Balestra and R. Mantegazza and S. Tzartos and M. Moretti and F. Clementi",
year = "1997",
doi = "10.1002/(SICI)1097-4598(199707)20:7<800::AID-MUS3>3.0.CO;2-B",
language = "English",
volume = "20",
pages = "800--808",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay

AU - Gotti, C.

AU - Balestra, B.

AU - Mantegazza, R.

AU - Tzartos, S.

AU - Moretti, M.

AU - Clementi, F.

PY - 1997

Y1 - 1997

N2 - To investigate the presence of antibodies in myasthenia gravis (MG) patients, we have developed a new reproducible and sensitive enzyme immunoassay (EIA-AChR), in which a β subunit-specific monoclonal antibody (mAb 73) immobilizes fetal calf acetylcholine receptors (AChRs). We tested 92 MG patients (42 with positive and 50 with negative antibody liters), 60 healthy controls, and 40 controls with other autoimmune diseases. EIA-AChR detected immunoglobulin G (IgG) titers in all of the seropositive samples, with a significant correlation between these and those obtained using the traditional immunoprecipitation method. Moreover, 5 seronegative patients at immunoprecipitation assay were positive at EIA-AChR. EIA-AChR was also useful in revealing: (1) a seropositive patient subpopulation with generalized MG who had Abs directed against α-Bungarotoxin binding sites; and (2) patients with IgM directed against fetal calf AChR (detected in 13 seronegative and 16 seropositive MG patients, and in 6 of the patients with other autoimmune diseases).

AB - To investigate the presence of antibodies in myasthenia gravis (MG) patients, we have developed a new reproducible and sensitive enzyme immunoassay (EIA-AChR), in which a β subunit-specific monoclonal antibody (mAb 73) immobilizes fetal calf acetylcholine receptors (AChRs). We tested 92 MG patients (42 with positive and 50 with negative antibody liters), 60 healthy controls, and 40 controls with other autoimmune diseases. EIA-AChR detected immunoglobulin G (IgG) titers in all of the seropositive samples, with a significant correlation between these and those obtained using the traditional immunoprecipitation method. Moreover, 5 seronegative patients at immunoprecipitation assay were positive at EIA-AChR. EIA-AChR was also useful in revealing: (1) a seropositive patient subpopulation with generalized MG who had Abs directed against α-Bungarotoxin binding sites; and (2) patients with IgM directed against fetal calf AChR (detected in 13 seronegative and 16 seropositive MG patients, and in 6 of the patients with other autoimmune diseases).

KW - Antibodies

KW - Enzyme-linked immunosorbent assay

KW - Immunoassay

KW - Myasthenia gravis

KW - Nicotinic acetylcholine receptor

UR - http://www.scopus.com/inward/record.url?scp=0030961662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030961662&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4598(199707)20:7<800::AID-MUS3>3.0.CO;2-B

DO - 10.1002/(SICI)1097-4598(199707)20:7<800::AID-MUS3>3.0.CO;2-B

M3 - Article

C2 - 9179151

AN - SCOPUS:0030961662

VL - 20

SP - 800

EP - 808

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 7

ER -